NORML Working to Reform Marijuana Laws

FDA Hearing On ‘Hemp-Derived CBD’ Today

In its written testimony, NORML Deputy Director Paul Armentano encourages the agency to act expeditiously to clarify confusion among both consumers and regulators with regard to the legality of specific CBD products. It further recommends that the FDA provide regulatory guidelines governing product manufacturing, standardization, and quality.

NORML Working to Reform Marijuana Laws

Clinical Trial: CBD Administration Reduces Heroin Cravings

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These conclusions add to the growing body of evidence that cannabis and its constituents represent an exit away from the use or abuse of other controlled substances rather than a supposed ‘gateway.'”

NORML Working to Reform Marijuana Laws

Election Night: Gubernatorial Victories Bode Well For 2019 Statewide Reform Prospects

Voters on election day decided in favor of several gubernatorial candidates who campaigned on promises to either address or enact statewide marijuana law reforms as Governor. NORML Deputy Director Paul Armentano said, “In 2019, we anticipate unprecedented legislative activity at the state level in favor of marijuana law reform legislation, and we expect to see several significant legislative victories before the year’s end.”

Marijuana and Heart Health

Breaking News: President Obama Issues New Medical Marijuana Guidelines

In what can only be described as major departure in the so-called ‘war on drugs’, the Obama Administration is issuing a new three page memo this morning [Paul Armentano updates: You can now read the memorandum, signed by Deputy Attorney General David W. Ogden, here. You can also share your thoughts with the White House on the administration’s decision via NORML’s Take Action Center here.] mapping out the federal government’s new guidelines for states that have laws protecting medical cannabis patients.